Physician profile
Barbara E Murray
NPI 1497773709
$9,343.17
in general payments reported to CMS, 2019-2025
9 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $465 · 2020: $57.83 · 2021: $2,160 · 2022: $6,660.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $5,175.00 | 2022 | |
| Janssen Research & Development, LLC | $3,645.00 | 2021-2022 | |
| Merck Sharp & Dohme LLC | $249.47 | 2019-2020 | |
| Paratek Pharmaceuticals, INC. | $78.12 | 2019 | |
| Tetraphase Pharmaceuticals, INC. | $70.29 | 2019 | |
| Astellas Pharma US INC | $46.22 | 2019 | |
| Melinta Therapeutics, LLC | $34.74 | 2019 | |
| Pfizer INC. | $31.07 | 2019 | |
| Allergan, INC. | $13.26 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Barbara Murray listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.